The Summer 2023 call for applications is open!
BETA.HEALTH wants to support and accelerate innovation projects at Danish hospitals to spark the development of new or improved treatments and clinical solutions for the benefit of patients and society.
In the current call for applications, BETA.HEALTH will award three types of grants:
- BETA.05: DKK 500.000
- BETA.10: DKK 1.000.000
- INDUSTRY.PARTNER.10: DKK 1.000.000
There are 15 grants in total: 12 BETA.05, 2 BETA.10 and 1 INDUSTRY.PARTNER.10.
You may apply for a BETA.HEALTH grant using our online application and grant management system.
Applicants must download and read this guide before applying.
IMPORTANT DATES
- 1 June 2023: Summer 2023 call opens
- 27 August 2023: Summer 2023 call application deadline
- 8 November 2023 (at the latest): All applicants receive notification of the Review Committee's decision
- 1 December 2023: Winter 2024 call opens
- 28 January 2023: Winter 2024 call application deadline
AREAS OF SUPPORT
The purpose of BETA.HEALTH grants is to support and accelerate innovation projects at Danish hospitals to amplify the development of new or improved treatments and clinical solutions for the benefit of patients and society.
Grant applicants must demonstrate how their innovation project leverages clinical research discoveries or other published research which can be exploited in a new way, a new clinical area or a new clinical context.
For the SUMMER CALL 2023 (Call 4) specifically, BETA.HEALTH will prioritise projects that clearly address:
- Capacity issues in healthcare systems
- Early detection in diagnostics, prediction models or digital workflows
- Personalised solutions to fit the needs of each patient, focused on value and outcome, regardless of location
Examples of solutions addressing the above issues could be digital, data- and/or device-driven solutions leading to:
- Increased diagnostic capacity
- Continuous and actionable decision-support
- Increased speed, place, and precision of diagnostics for early intervention, treatment and monitoring – e.g closer to patients and reduction in check-ups and follow-ups
- Prospectively validated prediction models that support optimal resource allocation in the healthcare system
BETA.HEALTH will not support:
- Projects that are solely focused on testing products that are already in the market
- Projects with a procurement rather than development focus
- Minor incremental improvement of existing solutions
- Projects with inadequate scaling potential
It is the applicant's responsibility to highlight how their project addresses issues that fall within the BETA.HEALTH purpose and areas of support.
Specific Areas of Support for the Industry Call
Early Detection
BETA.HEALTH and Roche aim to accelerate the development and implementation of new or improved clinical solutions that will enable earlier detection within lung oncology and ophthalmology.
Capacity Issues
BETA.HEALTH and Roche aim to accelerate the development and implementation of new or improved clinical solutions that will help solve the capacity challenges now and in the future within radiology/imaging, specifically within lung cancer or hematology, or pathology within lung or breast cancer, or hematology.
Health at Home
BETA.HEALTH and Roche aim to accelerate the development and implementation of new or improved clinical solutions that will enable ‘health at home’ solutions within breast or lung oncology, ophthalmology or hematology.
Grant applicants must showcase how their innovation project leverages or addresses one or more of these areas of support.
The review committee will award the INDUSTRY.PARTNER.10 grant based on the same assessment criteria as the regular BETA grants.
Please refer to the call guidelines for further details, or contact us at contact@betahealth.dk if you are in doubt about these 'areas of support'.
USE OF FUNDS
Grant funds may be used to fund external project costs, including:
- External consultants with competencies in, e.g. business development or a technical or clinical field
- External laboratory testing
- Equipment, including hardware and software
- Limited travel and accommodations
- Up to 20% of the grant to free resources for core project team members
Note that 5% of the grant will be reserved for program activities (i.e. project bootcamp/booster, education and acceleration activities from external providers). This corresponds to a fixed amount of 25,000 DKK or 50,000 DKK for BETA.05 or BETA.10/INDUSTRY.PARTNER.10 respectively.
Funding cannot be used for:
- Costs related to the publication and presentation of research findings
- Support of research projects with no intended development and/or implementation
- Direct funding (salary) of PhD students
EVALUATION OF APPLICATIONS
The BETA.HEALTH team screens and prepares applications for the BETA.HEALTH review committee. The initial screening is based on the information provided in the online application. All applications are screened and evaluated by the BETA.HEALTH team and review committee using the same tools and criteria to ensure consistency and equal opportunity. The BETA.HEALTH may reach out to applicants in a due diligence process to clarify missing or unclear information.
Ultimately, the BETA.HEALTH review committee awards grants based on their final evaluation approximately one month after the application deadline. Applicants are notified one week later.